JPMorgan Chase & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.32M | Sell |
38,015
-2,397
| -6% | -$272K | ﹤0.01% | 2803 |
|
|
2025
Q1 | $4.25M | Buy |
40,412
+2,651
| +7% | +$279K | ﹤0.01% | 2775 |
|
|
2024
Q4 | $4.05M | Sell |
37,761
-18,690
| -33% | -$2M | ﹤0.01% | 2911 |
|
|
2024
Q3 | $5.65M | Sell |
56,451
-7,321
| -11% | -$733K | ﹤0.01% | 2564 |
|
|
2024
Q2 | $5.37M | Buy |
63,772
+13,766
| +28% | +$1.16M | ﹤0.01% | 2490 |
|
|
2024
Q1 | $3.66M | Sell |
50,006
-12,873
| -20% | -$941K | ﹤0.01% | 2762 |
|
|
2023
Q4 | $4.49M | Buy |
62,879
+2,664
| +4% | +$190K | ﹤0.01% | 2637 |
|
|
2023
Q3 | $3.61M | Buy |
60,215
+24,481
| +69% | +$1.47M | ﹤0.01% | 2622 |
|
|
2023
Q2 | $2.58M | Sell |
35,734
-12,355
| -26% | -$891K | ﹤0.01% | 2890 |
|
|
2023
Q1 | $3.54M | Buy |
48,089
+9,256
| +24% | +$681K | ﹤0.01% | 2667 |
|
|
2022
Q4 | $2.59M | Sell |
38,833
-25,455
| -40% | -$1.7M | ﹤0.01% | 2800 |
|
|
2022
Q3 | $3.45M | Buy |
64,288
+891
| +1% | +$47.9K | ﹤0.01% | 2576 |
|
|
2022
Q2 | $3.53M | Sell |
63,397
-3,220
| -5% | -$179K | ﹤0.01% | 2637 |
|
|
2022
Q1 | $4.68M | Buy |
66,617
+2,620
| +4% | +$184K | ﹤0.01% | 2615 |
|
|
2021
Q4 | $6.17M | Sell |
63,997
-232
| -0.4% | -$22.4K | ﹤0.01% | 2433 |
|
|
2021
Q3 | $5.58M | Sell |
64,229
-27,185
| -30% | -$2.36M | ﹤0.01% | 2509 |
|
|
2021
Q2 | $7.48M | Buy |
91,414
+18,617
| +26% | +$1.52M | ﹤0.01% | 2362 |
|
|
2021
Q1 | $6.92M | Sell |
72,797
-6,265
| -8% | -$596K | ﹤0.01% | 2416 |
|
|
2020
Q4 | $4.91M | Buy |
79,062
+5,837
| +8% | +$362K | ﹤0.01% | 2444 |
|
|
2020
Q3 | $4.38M | Buy |
73,225
+36,627
| +100% | +$2.19M | ﹤0.01% | 2308 |
|
|
2020
Q2 | $2.55M | Sell |
36,598
-3,196
| -8% | -$223K | ﹤0.01% | 2548 |
|
|
2020
Q1 | $1.81M | Sell |
39,794
-116,519
| -75% | -$5.29M | ﹤0.01% | 2658 |
|
|
2019
Q4 | $10.2M | Buy |
156,313
+7,814
| +5% | +$508K | ﹤0.01% | 1756 |
|
|
2019
Q3 | $9.22M | Buy |
148,499
+111,096
| +297% | +$6.9M | ﹤0.01% | 1837 |
|
|
2019
Q2 | $2.66M | Sell |
37,403
-1,572
| -4% | -$112K | ﹤0.01% | 2513 |
|
|
2019
Q1 | $3.06M | Sell |
38,975
-72,568
| -65% | -$5.69M | ﹤0.01% | 2401 |
|
|
2018
Q4 | $9.44M | Buy |
111,543
+63,923
| +134% | +$5.41M | ﹤0.01% | 1703 |
|
|
2018
Q3 | $8.16M | Buy |
47,620
+33,241
| +231% | +$5.69M | ﹤0.01% | 1969 |
|
|
2018
Q2 | $1.86M | Sell |
14,379
-17,893
| -55% | -$2.31M | ﹤0.01% | 2852 |
|
|
2018
Q1 | $3.33M | Sell |
32,272
-36,885
| -53% | -$3.8M | ﹤0.01% | 2465 |
|
|
2017
Q4 | $5.91M | Buy |
69,157
+44,028
| +175% | +$3.76M | ﹤0.01% | 2144 |
|
|
2017
Q3 | $2.11M | Buy |
25,129
+13,627
| +118% | +$1.15M | ﹤0.01% | 2600 |
|
|
2017
Q2 | $871K | Buy |
11,502
+2,004
| +21% | +$152K | ﹤0.01% | 2962 |
|
|
2017
Q1 | $627K | Buy |
9,498
+7,363
| +345% | +$486K | ﹤0.01% | 3071 |
|
|
2016
Q4 | $135K | Buy |
2,135
+1,393
| +188% | +$88.1K | ﹤0.01% | 3789 |
|
|
2016
Q3 | $47K | Sell |
742
-5,502
| -88% | -$349K | ﹤0.01% | 3610 |
|
|
2016
Q2 | $465K | Buy |
6,244
+5,107
| +449% | +$380K | ﹤0.01% | 2999 |
|
|
2016
Q1 | $76K | Buy |
1,137
+977
| +611% | +$65.3K | ﹤0.01% | 3325 |
|
|
2015
Q4 | $11K | Buy |
+160
| New | +$11K | ﹤0.01% | 3601 |
|
|
2015
Q1 | – | Sell |
-28,708
| Closed | -$953K | – | 3473 |
|
|
2014
Q4 | $953K | Buy |
+28,708
| New | +$953K | ﹤0.01% | 2804 |
|
|
2013
Q4 | – | Sell |
-17,603
| Closed | -$476K | – | 3697 |
|
|
2013
Q3 | $476K | Sell |
17,603
-15,005
| -46% | -$406K | ﹤0.01% | 3336 |
|
|
2013
Q2 | $761K | Buy |
+32,608
| New | +$761K | ﹤0.01% | 3054 |
|